ContractTripartite Agreement • February 17th, 2022
Contract Type FiledFebruary 17th, 2022TRIPARTITE AGREEMENTTo Clinical Trial PRONOMOS TŘÍSTRANNÁ DOHODAKe Klinické Studii PRONOMOS between mezi The Centre Hospitalier Universitaire (CHU) de Saint- Etienne, having its head office at Hôpital Bellevue - 42055 SAINT-ETIENNE cedex 2 - France, represented by its Director, Monsieur Frédéric Boiron, duly authorized for the purpose of this agreement, Centre Hospitalier Universitaire (CHU) v Saint- Etienne, mající ústředí v Nemocnici Bellevue - 42055 SAINT-ETIENNE cedex 2 - Francie, zastupované ředitelem, panem Frédéricem Boironem, řádně pověřeným pro účely této dohody, hereafter refered to as ,Sponsor”, nadále jako “Zadavatel”, The Company FGK Clinical Research s.r.o. , ID No. 241 81 056 having its office at Polská 1283/18, 120 00 Praha 2, represented by its Managing Director Dr. Edgar Fenzl, appointed by the Sponsor with the authority to sign and execute on its responsibility this agreement in the name and on behalf of the Sponsor, Společnost FGK Clinical Research s.r.o., IČ: 24181
ContractTripartite Agreement • February 28th, 2017
Contract Type FiledFebruary 28th, 2017TRIPARTITE AGREEMENTTo Clinical Trial PRONOMOS TŘÍSTRANNÁ DOHODAKe Klinické Studii PRONOMOS between The Centre Hospitalier Universitaire (CHU) de Saint- Etienne, having its head office at Hôpital Bellevue - 42055 SAINT-ETIENNE cedex 2 - France, represented by its Director, Monsieur Frédéric Boiron, duly authorized for the purpose of this agreement, hereafter refered to as ,Sponsor”, The Company FGK Clinical Research s.r.o. , ID No. 241 81 056 having its office at Polská 1283/18, 120 00 Praha 2, represented by its Managing Director Dr. Edgar Fenzl, appointed by the Sponsor with the authority to sign and execute on its responsibility this agreement in the name and on behalf of the Sponsor, hereafter referred to as „CRO“, and Karlovarská krajská nemocnice a.s., ID No. 263658804 with its office Bezručova 1190/19, 360 01 Karlovy Vary, Czech Republic represented by MUDr. Josef März, Chairman of the Board, MUDr. Jiří Hofmann, Vice Chairman of the Board hereafter referred to as “Institution” a